Occurrence of acute lymphoblastic leukemia in a boy treated with growth hormone for growth retardation after irradiation to the brain tumor.
An 18-year-old male patient who had suffered from polyuria, nocturia and easy fatigability since childhood is described. A germ cell tumor in the suprahypophyseal region was diagnosed at the age of 13 years, and was treated by cranial irradiation. Growth retardation and other signs of hypophyseal deficiency successively occurred, and human growth hormone was administered for two years and five months from the age of 16 years until acute lymphoblastic leukemia developed. Adriamycin, vincristine and prednisolone therapy induced complete remission, but the patient died of disseminated intravascular coagulation two months later. The relationship between the occurrence of leukemia and administration of growth hormone is discussed.
Sasaki
U
U
Ehime Chuo Hospital.
Hara
M
M
Watanabe
S
S
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000532:radiotherapy; D004317:Doxorubicin / Q000008:administration & dosage; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology*; D013006:Growth Hormone / Q000009:adverse effects*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000532:radiotherapy; D011239:Prednisolone / Q000008:administration & dosage; D011878:Radiotherapy / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D013006:Growth Hormone; D011239:Prednisolone